Generic injectables are widely used in the treatment of various chronic diseases such as cancer, diabetes, cardiovascular diseases, respiratory diseases, rheumatoid arthritis, osteoarthritis, osteoporosis, etc. In the United States, these drugs form an important part of the public healthcare system and contribute in significant savings for the patients and healthcare providers. The US Generic Injectables Market reached a value of US$ 10 Billion in 2016, exhibiting a CAGR of more than 9% during 2009-2016. The market growth can be attributed to the low cost of these drugs as compared to their branded counterparts. Moreover, as there is limited price erosion and low competition in the market, the profit margins are significantly higher than commoditised generics.
Over the next few years, the market is expected to be driven by a number of favourable factors. The cases of chronic diseases have been increasing on account of ageing population, sedentary lifestyles and poor eating habits. This has resulted in a heightened demand for generic injectables. Furthermore, the drug shortages in the country coupled with speedy approvals by the USFDA are expected to boost the manufacturing of these drugs. Additionally, the patent expiry of a large number of branded injectable drugs is expected to support the market growth. As a result, the market is projected to reach a value of more than US$ 16 Billion by 2022, growing at a CAGR of around 8% during 2017-2022.
Request a free sample copy of US Generic Injectables Market Report @
The report has segmented the market on the basis of therapeutic area and covers oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular diseases, etc. Among these, oncology generic injectables represent the largest segment. The report has further analysed the various containers used for generic injectables including vials, premix, prefilled syringes and ampoules. On the basis of distribution channels, the report finds that hospitals dominate the market, accounting for the majority of the share. The report has also examined the competitive landscape of the market and provides the profiles of the key players operative in it. Some the major players are Hospira, Hikma, App, Sagent, Sandoz and Henry Shein, Inc.
This report provides a deep insight into the US generic injectables industry covering all its essential aspects. This ranges from a macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic injectables manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the US generic injectables industry in any manner.
Key Questions Answered in This Report:
How has the US generic injectables market performed so far and how will it perform in the coming years?
What are the price trends of generic injectables in the US?
What are the various stages in the value chain of the generic injectables industry?
What are the key driving factors and challenges in the US generic injectables industry?
What is the structure of the US generic injectables industry and who are the key players?
What is the degree of competition in the US generic injectables industry?
What are the profit margins in the generic injectables industry?
What are the key requirements for setting up a generic injectables manufacturing plant?
How are generic injectables manufactured?
What are the various unit operations involved in a generic injectables manufacturing plant?
What is the total size of land required for setting up a generic injectables manufacturing plant?
What are the machinery requirements for setting up a generic injectables manufacturing plant?
What are the raw material requirements for setting up a generic injectables manufacturing plant?
What are the packaging requirements for generic injectables?
What are the transportation requirements for generic injectables?
What are the utility requirements for setting up a generic injectables manufacturing plant?
What are the manpower requirements for setting up a generic injectables manufacturing plant?
What are the infrastructure costs for setting up a generic injectables manufacturing plant?
What are the capital costs for setting up a generic injectables manufacturing plant?
What are the operating costs for setting up a generic injectables manufacturing plant?
What will be the income and expenditures for a generic injectables manufacturing plant?
What is the time required to break-even?
Browse our full report with Table of Contents : https://www.bharatbook.com/healthcare-market-research-reports-927856/us-generic-injectables.html
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Follow us on : Twitter, Facebook, LinkedIn, Google Plus